PHP
AFIB

Parkman Healthcare Partners’s Acutus Medical Inc AFIB Stock Holding History

Parkman Healthcare Partners’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-794,145
Closed -$553K – 111
2023
Q3 		$553K Buy
794,145
+32,120
+4% +$20.8K 0.1% 100
2023
Q2 		$677K Buy
762,025
+108,304
+17% +$91.8K 0.12% 90
2023
Q1 		$493K Buy
653,721
+601,694
+1,157% +$785K 0.11% 78
2022
Q4 		$59.8K Buy
+52,027
New +$42.9K 0.02% 81

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Parkman Healthcare Partners's AFIB Position: Q4 2023 in Review

Parkman Healthcare Partners sold out of Acutus Medical Inc (AFIB) in Q4 2023, closing a stake of 794,145 shares — an estimated $553K sold.

Parkman Healthcare Partners first reported a position in AFIB in Q4 2022 and held it in 4 quarters. The position peaked at $677K in Q2 2023. 29 funds tracked by Wall St. Rank hold AFIB as of Q4 2023.

  • Parkman Healthcare Partners reported no remaining Acutus Medical Inc position as of Q4 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 794,145 Acutus Medical Inc shares in Q4 2023, an estimated $553K.
  • Parkman Healthcare Partners first reported a position in Acutus Medical Inc in Q4 2022 and held it in 4 quarters.
  • Parkman Healthcare Partners's Acutus Medical Inc position peaked at $677K in Q2 2023.
  • 29 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2023.

Based on Parkman Healthcare Partners's 13F filing for Q4 2023, filed 14 Feb 2024.